Literature DB >> 30031153

Clinical report of 8 patients with 49,XXXXY syndrome: Delineation of the facial gestalt and depiction of the clinical spectrum.

Anna L Burgemeister1, Eva Daumiller2, Gabriele du Bois2, Luitgard M Graul-Neumann3, Birgit Köhler4, Susanne Knecht5, Stefan Burgemeister6, Sarah Gronwald7, Martin H Maurer8, Birgit Zirn2.   

Abstract

49,XXXXY syndrome is a rare sex chromosome aneuploidy syndrome. Cognitive impairment with expressive language deficits in combination with developmental and speech dyspraxia are cardinal symptoms. Testicular insufficiency becomes apparent during adolescence. Neurological, musculoskeletal, genital, orthodontic and immunological anomalies are common and a higher incidence of congenital malformations has been described. Here we show the evolving clinical and facial phenotype of eight boys and men with 49,XXXXY, demonstrating an increasingly perceptible distinct facial gestalt over time. In addition, almost all patients had muscular hypotonia, radioulnar synostosis, white matter anomalies, fifth-finger clinodactyly, recurrent respiratory infections in early childhood and teeth anomalies. IQ scores ranged between 40 and 70. Though many boys showed short stature at some point in early childhood, most outgrew it. As more long term data of boys and men with 49,XXXXY become available, parents of affected boys can be counseled more specifically as to the expected course and spectrum of this rare chromosomal disorder. Moreover, the multidisciplinary support can be optimized und unnecessary diagnostics avoided.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  49,XXXXY; Sex chromosome pentasomy; White matter lesions

Mesh:

Year:  2018        PMID: 30031153     DOI: 10.1016/j.ejmg.2018.07.016

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  1 in total

1.  49,XXXXY syndrome: A case study and a systematic review of clinical features among the Iranian population.

Authors:  Mahboubeh Rajabzadeh; Nafiseh Taheri; Omid Jazayeri
Journal:  Clin Case Rep       Date:  2022-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.